[

serum institute

]
Adar Poonawalla, chief executive officer of Serum Institute of India. (File photo)

Biocon Biologics, Serum Institute announce strategic alliance

ANI | , Bengaluru
PUBLISHED ON SEP 17, 2021 09:54 AM IST
The two companies will enter Service Level Agreements (SLAs) for manufacturing and distribution of the vaccines and antibodies.
Sputnik V has, so far, been registered in 67 countries accounting for over 3.5 billion people.
Sputnik V has, so far, been registered in 67 countries accounting for over 3.5 billion people.

Serum to produce Russia's Sputnik V vaccine from September: RDIF CEO

By hindustantimes.com | Written by Sohini Goswami, New Delhi
PUBLISHED ON JUL 13, 2021 01:55 PM IST
The CEO of Russian Direct Investment Fund, Kirill Dmitriev, said some other manufactures are also ready to produce this anti-Coronavirus vaccine in India.
Dark clouds over the sky during Cyclone Tauktae at Vellayil Harbor in Kozhikode on May 17.(PTI)
Dark clouds over the sky during Cyclone Tauktae at Vellayil Harbor in Kozhikode on May 17.(PTI)

News updates from HT: Another cyclone may form over Bay of Bengal, warns IMD

By hindustantimes.com, Hindustan Times, New Delhi
PUBLISHED ON MAY 18, 2021 08:56 PM IST
  • Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.
The Taste with Vir Sanghvi: The dream of a modern India is dying(Twitter/reuterspictures/dansiddiqui)
The Taste with Vir Sanghvi: The dream of a modern India is dying(Twitter/reuterspictures/dansiddiqui)

The Taste with Vir Sanghvi: The dream of a modern India is dying

UPDATED ON MAY 06, 2021 01:21 PM IST
  • In this week's The Taste, Vir Sanghvi writes, "Such is the despondency over our politicians that many people are now actively considering emigrating to other countries"
Serum Institute of India Ltd., the world’s largest vaccine maker and the country’s main supplier of Covid-19 shots, is racing to keep up with states’ orders.(Reuters file photo)
Serum Institute of India Ltd., the world’s largest vaccine maker and the country’s main supplier of Covid-19 shots, is racing to keep up with states’ orders.(Reuters file photo)

Govt's biggest Serum Covid-19 vaccine order covered just 4% of population

Bloomberg |
UPDATED ON MAY 03, 2021 03:57 PM IST
Serum is licensed to manufacture Covid shots from AstraZeneca Plc. and Novavax Inc.
Covishield, which has been developed by Oxford-AstraZeneca against Covid-19, is locally manufactured and sold by the Serum Institute of India (SII).(Bloomberg)
Covishield, which has been developed by Oxford-AstraZeneca against Covid-19, is locally manufactured and sold by the Serum Institute of India (SII).(Bloomberg)

AstraZeneca serves legal notice to Serum Institute over supply delays

Agencies | By HT Correspondent
UPDATED ON APR 08, 2021 06:43 AM IST
On March 25, Covax announced a major setback in its vaccine rollout because a surge in infections in India caused the Serum Institute of India (SII) to cater to domestic demand, resulting in a delay in global shipments of up to 90 million doses.
Doctor receives a serum institute of India's COVID-19 vaccine called COVISHIELD during the coronavirus disease (COVID-19) vaccination drive.
Doctor receives a serum institute of India's COVID-19 vaccine called COVISHIELD during the coronavirus disease (COVID-19) vaccination drive.

SII delays vaccines for private sale in Bangladesh to focus on national campaign

Reuters |
PUBLISHED ON FEB 04, 2021 02:51 PM IST
Beximco last week received 5 million of the 30 million doses it had ordered from SII for Bangladesh's immunisation programme that begins next week.
Maharashtra Chief Minister Uddhav Thackeray speaks as he attends a meeting through video conferencing in Mumbai. (ANI Photo)
Maharashtra Chief Minister Uddhav Thackeray speaks as he attends a meeting through video conferencing in Mumbai. (ANI Photo)

SII fire accident or sabotage to be known after probe, says Uddhav Thackeray

PTI |
PUBLISHED ON JAN 22, 2021 06:15 PM IST
Five men died in the fire that broke out in a five- storeyed under-construction building in the SII's Manjari premises in Pune on Thursday.
A smoke rises from fire at Serum Institute of India in Pune, India January 21, 2021. REUTERS/Stringer(REUTERS)
A smoke rises from fire at Serum Institute of India in Pune, India January 21, 2021. REUTERS/Stringer(REUTERS)

Damage in fire worth 1K crore, Covid vaccine supply not to be impacted: SII CEO

Written by Prashasti Singh, New Delhi
UPDATED ON JAN 22, 2021 06:22 PM IST
In a statement issued earlier, SII officials had said the fire would impact the production of BCG and Rotavirus vaccines in future.
The Maharashtra government ordered a probe into the incident. State health minister Rajesh Tope said initial findings suggested that the fire was caused due to welding work and spread fast due to the presence of inflammatory material on the premises.(REUTERS)
The Maharashtra government ordered a probe into the incident. State health minister Rajesh Tope said initial findings suggested that the fire was caused due to welding work and spread fast due to the presence of inflammatory material on the premises.(REUTERS)

5 dead as fire breaks out at Serum facility

By Shalaka Shinde, Pune
PUBLISHED ON JAN 22, 2021 06:46 AM IST
Officials said at least four people were rescued from SII’s Manjari premises in an operation spanning over an hour to bring the fire under control and save those trapped.
Workers rush out of the building after fire breaks out at Serum Institute of India, Pune, on Thursday. (PTI)
Workers rush out of the building after fire breaks out at Serum Institute of India, Pune, on Thursday. (PTI)

'Anguished': PM Modi tweets after fire kills 5 at Pune's Serum Institute

By hindustantimes.com, HT Correspondent | Edited by Poulomi Ghosh
UPDATED ON JAN 21, 2021 10:58 PM IST
PM Modi prayed for speedy recovery of those who have been injured in the accident.
Twenty-two boxes containing 1,200 vials each of the vaccine was brought to the hospital’s utility block that has been retrofitted with 90 deep freezers, which can store 4.1 million doses of the vaccine. (Representative Image)
Twenty-two boxes containing 1,200 vials each of the vaccine was brought to the hospital’s utility block that has been retrofitted with 90 deep freezers, which can store 4.1 million doses of the vaccine. (Representative Image)

Vaccine vials land in city, Serum moves 6.4m doses

UPDATED ON JAN 13, 2021 01:24 AM IST
The first consignment of 264,000 doses of Covishield reached Delhi’s central storage facility at the Rajiv Gandhi Super Specialty Hospital (RGSSH) in the afternoon around high security, according to officials aware of the developments.
First consignment of Covishield vaccine, dispatched from Pune's Serum Institute of India, being transported in a temperature-controlled truck to a storage facility, in Bengaluru on Tuesday.(PTI Photo)
First consignment of Covishield vaccine, dispatched from Pune's Serum Institute of India, being transported in a temperature-controlled truck to a storage facility, in Bengaluru on Tuesday.(PTI Photo)

'When every moment counted', tweets minister Hardeep Puri on vaccine drive

By hindustantimes.com | Edited by Amit Chaturvedi
PUBLISHED ON JAN 12, 2021 11:02 PM IST
In the vaccination drive scheduled to begin on January 16, the healthcare and frontline workers will be inoculated in the first phase.
Covishield, along with Bharat Biotech’s Covaxin, were approved for restricted emergency use by the Drugs Controller General of India (DGCI) on January 3 (Sunday).(Reuters Photo)
Covishield, along with Bharat Biotech’s Covaxin, were approved for restricted emergency use by the Drugs Controller General of India (DGCI) on January 3 (Sunday).(Reuters Photo)

All you need to know about SII vaccine 'Covishield'| 10 points

By hindustantimes.com | Edited by Harshit Sabarwal, New Delhi
UPDATED ON JAN 12, 2021 11:16 PM IST
The first 100 million doses of the vaccine has been provided to the government at the cost of 200 per dose, with Serum Institute of India's (SII’s) chief executive officer (CEO) and owner Adar Poonawalla adding that the cost will increase later on.
Adar Poonawalla hopes SII will get emergency-use authorisation of its vaccine candidate by December. (HT Photo)
Adar Poonawalla hopes SII will get emergency-use authorisation of its vaccine candidate by December. (HT Photo)

Vaccination drive in India may start in January, says Adar Poonawalla as Serum Institute hopes to get nod by December

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Poulomi Ghosh
UPDATED ON DEC 12, 2020 01:58 PM IST
Pune’s SII is preparing to manufacture enough vaccines for the government as well as private makers.
A medic checks the temperature of ice packs in a deep freezer at a Covid-19 vaccine storage facility in Ahmedabad.(PTI)
A medic checks the temperature of ice packs in a deep freezer at a Covid-19 vaccine storage facility in Ahmedabad.(PTI)

Covid-19 vaccine: Data India seeks from Serum Institute, Bharat Biotech; Canada’s approval to Pfizer vaccine shot | 10 points

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Poulomi Ghosh
UPDATED ON DEC 10, 2020 08:33 AM IST
Bharat Biotech will have to submit the safety and efficacy data from the ongoing phase 3 clinical trial in the country.
The three organisations are working in tandem for the global development plan.(Representational Image)
The three organisations are working in tandem for the global development plan.(Representational Image)

IAVI, Serum Institute sign pact with Merck to develop coronavirus neutralising antibodies

Hindustan Times, New Delhi | By HT Correspondent | Edited by Joydeep Sen Gupta
UPDATED ON OCT 23, 2020 01:13 PM IST
The antibodies have been co-invented by IAVI and Scripps Research, a non-profit American biomedical research facility, as innovative interventions to rein in the global spread of the Covid-19 pandemic
A research scientist works inside a laboratory of Serum Institute of India.(File photo)
A research scientist works inside a laboratory of Serum Institute of India.(File photo)

Covid-19: Serum Institute to produce additional 100 million vaccine doses

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON SEP 29, 2020 03:38 PM IST
The initiative brings the total number of vaccine doses to be covered by the partnership to an aggregate of up to 200 million doses, following the initial agreement for up to 100 million doses, which were announced in August
AstraZeneca said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.(REUTERS)
AstraZeneca said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.(REUTERS)

Serum Institute says India trials of Covid-19 vaccine ongoing

Bengaluru | By Reuters| Posted by Susmita Pakrasi
PUBLISHED ON SEP 09, 2020 05:10 PM IST
AstraZeneca said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.
SII is the world’s largest vaccine manufacturer by the number of doses produced and sold globally. (Image for representational purpose only).(AP)
SII is the world’s largest vaccine manufacturer by the number of doses produced and sold globally. (Image for representational purpose only).(AP)

Serum Institute to begin phase 2 trial of Oxford Covid-19 vaccine candidate today

Hindustan Times, New Delhi | By Rhythma Kaul
PUBLISHED ON AUG 25, 2020 09:57 AM IST
17 sites have been selected to conduct the phase II/III trials, observer-blind, randomized, controlled study, to check the safety and immune response of the vaccine candidate among healthy Indian adults
Construction underway on the Delhi-Meerut Expressway project.(Sakib Ali /Hindustan Times)
Construction underway on the Delhi-Meerut Expressway project.(Sakib Ali /Hindustan Times)

News updates from Hindustan Times: Delhi to set up camps, help construction workers register for welfare funds and all the latest news

Hindustan Times, New Delhi | By hindustantimes.com
UPDATED ON AUG 23, 2020 04:49 PM IST
Here are today’s top news, analysis and opinion. Know all about the latest news and other news updates from Hindustan Times.
In this handout photo released by the University of Oxford blood samples from coronavirus vaccine trials are handled inside the Jenner Institute in Oxford, England.(AP Photo)
In this handout photo released by the University of Oxford blood samples from coronavirus vaccine trials are handled inside the Jenner Institute in Oxford, England.(AP Photo)

Serum Institute clarifies after reports claim free Covid-19 vaccine shots in 73 days

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Meenakshi Ray
UPDATED ON AUG 24, 2020 11:51 AM IST
Serum Institute of India, the world’s largest vaccine manufacturer, said it will confirm its availability officially only once the vaccine is proven immunogenic and efficacious.
It is mandatory for India bound travellers to fill up self declaration forms.(AP)
It is mandatory for India bound travellers to fill up self declaration forms.(AP)

News updated from Hindustan Times: Online filing of self declaration and exemption forms to start for international arrivals and all the latest news

Hindustan Times, New Delhi | By hindustantimes.com
UPDATED ON AUG 07, 2020 05:08 PM IST
Here are today’s top news, analysis and opinion at this hour. Know all about the latest news and other news updates from Hindustan Times.
The trials are likely to begin within the week, according to people aware of the matter.(AP)
The trials are likely to begin within the week, according to people aware of the matter.(AP)

Serum Institute gets nod for Oxford vaccine trials

Hindustan Times, New Delhi | By Anonna Dutt and Rhythma Kaul, New Delhi
UPDATED ON AUG 04, 2020 01:15 AM IST
This would make the Oxford-AstraZeneca vaccine – called Covishield – the first one to enter phase II and III trials in India.
On July 20, the initial trial results for the vaccine candidate, Covishield, which were made public by Oxford University had shown promising results.(Reuters)
On July 20, the initial trial results for the vaccine candidate, Covishield, which were made public by Oxford University had shown promising results.(Reuters)

Serum Institute gets regulatory nod for phase 2/3 trials of Oxford Covid vaccine

Hindustan Times, New Delhi | By HT Correspondent
UPDATED ON AUG 03, 2020 11:20 AM IST
A senior official in the Central Drugs Standard Control Organisation (CDSCO) said, “The subject expert committee that went through the data and protocol submitted for the trial was satisfied with the results and based on their opinion the DCGI permitted its trial in India.”
SHARE
Story Saved